Opthea (ASX:OPT) secures up to US$260m in funding for OPT-302 trials
Biopharmaceutical company Opthea (OPT) receives binding commitments for a US$90 million (A$127…
Opthea Limited (ASX:OPT)
About Opthea Limited
Key Information
OPT In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 15/04/2024 | Notification regarding unquoted securities - OPT | 15.55KB | 181 |
| 15/04/2024 | Notification regarding unquoted securities - OPT | 17.94KB | 166 |
| 09/04/2024 | Opthea Appoints John Han, PharmD, as VP Medical Affairs | 690.17KB | 2.2K |
| 05/04/2024 | Price Sensitive PS Opthea Corporate Presentation - April 2024 | 2.03MB | 1.5K |
| 05/04/2024 | Opteha to Participate in the 23rd Needham Virtual Conference | 203.2KB | 706 |
| 04/04/2024 | Final Director's Interest Notice DS | 223.78KB | 208 |
| 04/04/2024 | Initial Director's Interest Notice Sujal Shah | 201.37KB | 197 |
| 04/04/2024 | Opthea Appoints Sujal Shah to the Board of Directors | 200.57KB | 845 |